PL BioScience GmbH logo

PL BioScience GmbH

We at PL BioScience are experts in cell culture supplements derived from human Platelets. Our mission is to enhance the advances in cellular research and therapy with one forward-looking Technology: ELAREM™. The ELAREM™ Platform unites tailored cell culture supplements based on Human Platelet Lysate. The human origin combined with a rich growth factor content not only supports cell growth, but also enables various applications: The products cover all needs of cell expansion in academic research, pre-clinical research and cellular therapy. This ensures seamless transitions in regenerative medicine – from lab to patients in need. Our story goes back to 2015 and the idea to deliver animal component-free cell culture supplements. Today, we have changed the possibilities of cell expansion: Researchers switch from Fetal Bovine Serum to our animal suffering-free products. Stem Cell Therapy benefits the regeneration potential of our platelet-derived products. And we keep moving forward. Let's create the future of cell expansion together and join us on our mission.

PL BioScience GmbH logo

PL BioScience GmbH

PL BioScience provides animal-free cell culture solutions based on human platelet lysate technology, serving researchers and manufacturers in regenerative medicine.

Company Size

11-50 employees

Location

Germany

About

We at PL BioScience are experts in cell culture supplements derived from human Platelets. Our mission is to enhance the advances in cellular research and therapy with one forward-looking Technology: ELAREM™. The ELAREM™ Platform unites tailored cell culture supplements based on Human Platelet Lysate. The human origin combined with a rich growth factor content not only supports cell growth, but also enables various applications: The products cover all needs of cell expansion in academic research, pre-clinical research and cellular therapy. This ensures seamless transitions in regenerative medicine – from lab to patients in need. Our story goes back to 2015 and the idea to deliver animal component-free cell culture supplements. Today, we have changed the possibilities of cell expansion: Researchers switch from Fetal Bovine Serum to our animal suffering-free products. Stem Cell Therapy benefits the regeneration potential of our platelet-derived products. And we keep moving forward. Let's create the future of cell expansion together and join us on our mission.

Needs Assessment

Active buying signals and potential business opportunities

Technology Requirements

Cell culture supplements, particularly human platelet lysate.

2D and 3D cell culture solutions.

Xeno-free cell culture supplements and alternatives to FBS.

Products compatible with organ-on-a-chip and organoid technologies.

ELAREM™ products, Fibrinogen-Depleted Human Platelet Lysate, Cell Database

Cell culture media components

ELAREM™ Technology, Human Platelet Lysate Technology

Service Requirements

Technical support and product information.

Technical advice and support related to ELAREM™ products.

Sample requests for product evaluation.

Seeking advise or insight to determine the optimal Human Platelet Lysate solution for research projects.

Technical Support is listed in the menu.

Infrastructure Requirements

Laboratory equipment for cell expansion and culture.

Cell culture supplements to maintain cells under lab conditions.

ISO 9001:2015 certified Quality Management System.

GMP-grade supplements for cell therapy.

AI Insights

Growth Trajectory

With Series A financing and a focus on animal-free cell culture media, PL BioScience is poised for significant growth in the regenerative medicine market.

Market Opportunity

PL BioScience has a strong market position as a provider of fibrinogen-depleted HPL products, allowing them to capitalize on the increasing demand for animal-free cell culture solutions.

Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats